MitoCareX Bio Revenue
Biotechnology Research • 
Nes Ziona, Center District, Israel • 1-10 Employees
$
MitoCareX Bio revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | $400,000 |
Key Contact at MitoCareX Bio
Alon Silberman
Founder And Chief Scientific Officer
Company overview
| Headquarters | Nes Ziona, Center District, Israel |
| Website | |
| NAICS | 541714 |
| Keywords | Drug Discovery, Transporters, Structural Biology, Computational Chemistry |
| Founded | 2022 |
| Employees | 1-10 |
| Socials |
About MitoCareX Bio
MitoCareX Bio is a drug discovery company focusing on the discovery and development of novel therapies for hard-to-treat lung cancer by targeting mitochondrial transporters (SLC25 protein family).
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Manager
Senior
Employees by Department
MitoCareX Bio has 2 employees across 2 departments.
Departments
Number of employees
Canada
United States
Germany
United Kingdom
DenmarkFrequently asked questions
MitoCareX Bio is located in Nes Ziona, Center District, IL.
MitoCareX Bio generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.
MitoCareX Bio has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
MitoCareX Bio was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.
MitoCareX Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
MitoCareX Bio has raised a total of $400,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
